MetLife Investment Advisors LLC boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 178,601 shares of the conglomerate’s stock after buying an additional 2,207 shares during the quarter. MetLife Investment Advisors LLC’s holdings in Danaher were worth $23,579,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of DHR. Norges Bank acquired a new position in shares of Danaher in the fourth quarter valued at approximately $747,082,000. Oregon Public Employees Retirement Fund grew its position in shares of Danaher by 10,085.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 6,795,666 shares during the last quarter. Jennison Associates LLC acquired a new position in shares of Danaher in the first quarter valued at approximately $489,930,000. Findlay Park Partners LLP grew its position in shares of Danaher by 25.0% in the fourth quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock valued at $473,836,000 after purchasing an additional 920,000 shares during the last quarter. Finally, 1832 Asset Management L.P. grew its position in shares of Danaher by 74.3% in the fourth quarter. 1832 Asset Management L.P. now owns 2,129,142 shares of the conglomerate’s stock valued at $219,310,000 after purchasing an additional 907,593 shares during the last quarter. 78.82% of the stock is currently owned by institutional investors.
Shares of NYSE:DHR opened at $139.63 on Monday. The company has a market cap of $99.97 billion, a P/E ratio of 30.89, a P/E/G ratio of 2.70 and a beta of 0.95. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $140.25. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.06. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the business posted $0.99 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. On average, analysts anticipate that Danaher Co. will post 4.77 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.49%. The ex-dividend date is Thursday, June 27th. Danaher’s payout ratio is presently 15.04%.
In other Danaher news, SVP William King sold 12,950 shares of the company’s stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the completion of the sale, the senior vice president now directly owns 29,070 shares in the company, valued at $3,776,774.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the company’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $131.30, for a total value of $24,143,181.40. Following the sale, the chief executive officer now owns 302,377 shares of the company’s stock, valued at $39,702,100.10. The disclosure for this sale can be found here. Insiders have sold 453,448 shares of company stock valued at $59,724,640 over the last 90 days. Corporate insiders own 11.40% of the company’s stock.
Several research firms have recently commented on DHR. Wolfe Research began coverage on Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating on the stock. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research report on Tuesday, April 9th. Deutsche Bank increased their price target on Danaher to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Needham & Company LLC reissued a “buy” rating and set a $141.00 price target (up previously from $138.00) on shares of Danaher in a research report on Wednesday, April 17th. Finally, Piper Jaffray Companies began coverage on Danaher in a research report on Tuesday, June 11th. They set a “neutral” rating and a $148.00 price target on the stock. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $133.00.
ILLEGAL ACTIVITY NOTICE: This story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.dispatchtribunal.com/2019/06/17/danaher-co-nysedhr-holdings-boosted-by-metlife-investment-advisors-llc.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: How do candlesticks reflect price movement?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.